Privia Health Group, Inc.

NASDAQ:PRVA

Medical - Healthcare Information Services

Healthcare
$24.60 +0.62%

+$0.15 today

Market cap
$3.14B
Beta
0.87
P/E (TTM)
134.4
EPS (TTM)
$0.18
52W Low $18.77High $26.51

Volume 2.38M

Average 0.95M

PRVA Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Privia Health Group, Inc.NASDAQ: PRVA

Accounts Payables · Q2 FY2026 · quarter ended Jun 2026

Accounts payables declines year over year

Q2 FY2026 accounts payables of $32.31M fell 37.5% year over year, ahead of the -94.7% change in trailing-twelve-month accounts payables. Sequentially, it fell 1.7% from the prior quarter. Over 3 fiscal years it compounded at +29.3% a year.

Context

  • Accounts payables amounted to 0.7% of revenue in FY2025, down 2.3 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -37.5% holds above the trailing-twelve-month pace of -94.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$32.31M-1.7% QoQ
Last fiscal yearDec 2025
$14.82M-71.9% YoY
LTMJun 2026
$6.5M-94.7% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-37.5%——
1 year-71.9%——
3-year CAGR+29.3%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
14.82M USD
Year-over-year change
-71.9%

Accounts Payables vs competitors

How PRVA compares with its peers on the latest reported figures

  • PRVA's LTM Jun 2026 accounts payables of $6.5M is the 4th largest of the 10 companies compared; the peer median is $0.
  • Its year-over-year change of -94.7% is the 7th highest of 9, against a peer median of +40.2%.
  • Accounts payables amounts to 0.3% of revenue for PRVA, versus a peer median of 0.5%.
PRVA Competitors Peer median
Accounts Payables for PRVA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EVHEvolent Health, Inc.LTM Mar 2026$8.76M -45.0%-20.4%0.5%
TDOCTeladoc Health, Inc.LTM Mar 2026$8.01M -162.3%+82.8%0.3%
PHRPhreesia, Inc.LTM Apr 2026$7.16M +451.4%+3.3%1.4%
PRVAPrivia Health Group, Inc.LTM Jun 2026$6.5M -94.7%+29.3%0.3%
AMWLAmerican Well CorporationLTM Mar 2026$5.11M +1834.5%-10.6%2.2%
OMDAOmada HealthLTM Mar 2026$3.88M +191.0%—1.4%
CCLDCareCloud, Inc.LTM Mar 2026$3.55M -19.6%—2.9%
HCATHealth Catalyst, Inc.LTM Mar 2026$91K -97.7%+34.8%0.0%
AGLAgilon Health, Inc.LTM Mar 2026$0 ——0.0%
ASTHAstrana Health, Inc.LTM Mar 2026$0 +100.0%+66.8%0.0%
Peer median (excluding PRVA) $0+40.2%+19.0%0.5%

Competitors are the stored peer set for PRVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(190.65M)(12.06M)23.08M14.39M22.92M
Depreciation & Amortization2.46M4.57M6.53M7.27M9.91M
Deferred Income Tax(28.41M)(7M)7.47M8.82M10.87M
Stock-Based Compensation253.53M67.36M000
Change in Working Capital17.97M(6.35M)8.66M19.47M44.29M
Accounts Receivables(14.64M)(72.2M)(96.88M)(19.82M)(36.67M)
Inventory00000
Accounts Payables06.85M118.36M52.85M14.82M
Other Working Capital32.61M59M(12.82M)(13.55M)66.14M
Other Non-Cash Items157K687K35.05M59.34M75.42M
Operating Cash Flow55.06M47.2M80.79M109.28M163.4M
Capital Expenditures(547K)(104K)(113K)(5.02M)(1.2M)
Acquisitions (Net)(32.23M)125K(47.89M)(5.3M)(181.72M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities0(125K)001.35M
Investing Cash Flow(32.78M)(104K)(48.01M)(10.33M)(181.57M)
Debt Repayment(875K)(33.25M)00(2.46M)
Common Stock Issued223.69M13.45M8.74M2.68M8.05M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(9.15M)125K001.11M
Financing Cash Flow213.66M(19.68M)8.74M2.68M6.7M
Effect of Forex Changes00000
Net Change in Cash235.94M27.42M41.52M101.64M(11.46M)
Free Cash Flow54.51M47.09M80.67M104.26M162.2M

Privia Health Group, Inc.

NASDAQ:PRVA

Intrinsic Alpha fair value

Locked

Current Price

$24.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.